Coenzyme Q10 in the human retina

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 4, 2009, Pages 1814-1818

  Qu, Jinfeng ^a,b   Kaufman, Yardana ^a   Washington, Ilyas ^a  

^a NewYork Presbyterian Hospital   (United States)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; UBIDECARENONE; DRUG DERIVATIVE; UBIQUINONE;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CHOROID; CONTROLLED STUDY; FEMALE; FREEZE DRYING; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RETINA; TISSUE LEVEL; ENZYMOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHYSIOLOGY;

ADULT; AGED, 80 AND OVER; AGING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; RETINA; UBIQUINONE;

EID: 64049113767     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2656     Document Type: Article

References (63)

1. Frei B, Kim MC, Ames BN. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc Natl Acad Sci USA.1990;87(12):4879-4883.
2. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A. 1991;88:1646-1650.
3. Crane FL. Biochemical functions of coenzyme Q10. J Am Coll Nutr. 2001;20:591-598.
4. Echtay KS, Winkler E, Klingenberg M. Coenzyme Q is an obligatory cofactor for uncoupling protein function. Nature. 2000;408:609-613.
5. Horvath TL, Diano S, Leranth C, et al. Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. Endocrinology. 2003;144: 2757-2760.
6. Miles MV, Hornc PS, Tanga PH, et al. Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. Clin Chim Acta. 2004;342:139-144.
7. Söderberg M, Edlund C, Kristensson K, Dallner G. Lipid compositions of different regions of the human brain during aging. J Neurochem. 1990;54:415-423.
8. Bliznakov EG. Aging, mitochondria, and coenzyme Q10: the neglected relationship. Biochimie (Paris). 1999;81(12):1131-1132.
9. Aguilaniu H, Durieux J, Dillin A. Metabolism, ubiquinone synthesis, and longevity. Genes Dev. 2005;19:2399-2406.
10. Kalén A, Appelkvist EL, Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids. 1989;24:579-584.
11. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134.
12. Dusting GJ, Triggle C. Are we over oxidized? Oxidative stress, cardiovascular disease, and the future of intervention studies with antioxidants. Vasc Health Risk Manag. 2005;1:93-97.
13. Fernandez MM, Afshari NA. Nutrition and the prevention of cataracts. Curr Opin Ophthalmol. 2008;19:66-70.
14. Galaris D, Mantzaris M, Amorgianiotis C. Oxidative stress and aging: the potential role of iron. Hormones (Athens). 2008;7:114-122.
15. Hsiai T, Berliner JA. Oxidative stress as a regulator of murine atherosclerosis. Curr Drug Targets. 2007;8:1222-1229.
16. Nunomura A, Moreira PI, Lee HG, et al. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol Disord Drug Targets. 2007;6:411-423.
17. Shen JK, Dong A, Hackett SF, Bell WR, Green WR, Campochiaro PA. Oxidative damage in age-related macular degeneration. Histol Histopathol. 2007;22:1301-1308.
18. Virgolici B, Stoian I, Muscurel C, Maracine M, Moraru C, Dinu V. Plasma redox status and premature onset of senile cataract. Rom J Intern Med. 2007;45:59-65.
19. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001;119:1439-1452.
20. Tanga PH, Milesa MV, Milesa L, et al. Measurement of reduced and oxidized coenzyme Q9 and coenzyme Q10 levels in mouse tissues by HPLC with coulometric detection. Clin Chim Acta. 2004;341: 173-184.
21. Williams DL. Oxidative stress and the eye. Vet Clin North Am Small Anim Pract. 2008;38:179-192, vii.
22. Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res. 2001;20:175-208.
23. Whikehart DR. Biochemistry of the Eye. Boston: Butterworth-Heinemann; 1994.
24. Do TQ, Schultz JR, Clarke CF. Enhanced sensitivity of ubiquinone-deficient mutants of Saccharomyces cerevisiae to products of autoxidized polyunsaturated fatty acids. Proc Natl Acad Sci U S A. 1996;93:7534-7539.
25. Elliott MH, Nash ZA, Takemori N, Fliesler SJ, McClellan ME, Naash MI. Differential distribution of proteins and lipids in detergent-resistant and detergent-soluble domains in rod outer segment plasma membranes and disks. J Neurochem. 2008;104:336-352.
26. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19: 205-221.
27. Dunaief JL. Iron induced oxidative damage as a potential factor in agerelated macular degeneration: the Cogan Lecture. Invest Ophthalmol Vis Sci. 2006;47:4660-4664.
28. Hollyfield JG, Bonilha VL, Rayborn ME, et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med. 2008;14:194-198.
29. Lu L, Hackett SF, Mincey A, Lai H, Campochiaro PA. Effects of different types of oxidative stress in RPE cells. J Cell Physiol. 2006;206:119-125.
30. Chida M, Suzuki K, Nakanishi-Ueda T, et al. In vitro testing of antioxidants and biochemical end-points in bovine retinal tissue. Ophthalmic Res. 1999;31:407-415.
31. Kamei M, Yoneda K, Kume N, et al. Scavenger receptors for oxidized lipoprotein in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48:1801-1807.
32. Suzuki M, Kamei M, Itabe H, et al. Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol Vis. 2007;13:772-778.
33. Yamada Y, Tian J, Yang Y, et al. Oxidized low density lipoproteins induce a pathologic response by retinal pigmented epithelial cells. J Neurochem. 2008;105:1187-1197.
34. Feeney-Burns L, Hilderbrand E, Eldridge S. Aging human RPE: morphometric analysis of macular, equatorial and peripheral cells. Invest Ophthalmol Vis Sci. 1984;25:195-200.
35. Katz ML. Potential role of retinal pigment epithelial lipofuscin accumulation in age-related macular degeneration. Arch Gerontol Geriatr. 2002;34:359-370.
36. Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism of RPE aging and age-related macular degeneration. Exp Eye Res. 2003;76:397-403.
37. Nordgaard CL, Karunadharma PP, Feng X, Olsen TW, Ferrington DA. Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. 2008;49: 2848-2855.
38. Evans J. Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and metaanalysis. Eye. 2008;22(6):751-760.
39. Evans JR. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2006; CD000254.
40. Hogg R, Chakravarthy U. AMD and micronutrient antioxidants. Curr Eye Res. 2004;29:387-401.
41. Petrukhin K. New therapeutic targets in atrophic age-related macular degeneration. Expert Opin Ther Targets. 2007;11:625-639.
42. Schmidt-Erfurth U. Nutrition and retina. Dev Ophthalmol. 2005; 38:120-147.
43. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417-1436.
44. Farnsworth CC, Dratz EA. Oxidative damage of retinal rod outer segment membranes and the role of vitamin E. Biochim Biophys Acta. 1976;443:556-570.
45. Dilley RA, McConnell DG. Alpha-tocopherol in the retinal outer segment of bovine eyes. J Membr Biol. 1970;2:317-323.
46. SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol. 2007;125:1225-1232.
47. Alleva R, Tomasetti M, Battino M, Curatola G, Littarru GP, Folkers K. The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions. Proc Natl Acad Sci USA.1995;92:9388-9391.
48. Wang X, Quinn PJ. Vitamin E and its function in membranes. Prog Lipid Res. 1999;38:309-336.
49. Friedrichson T, Kalbach HL, Buck P, van Kuijk FJ. Vitamin E in macular and peripheral tissues of the human eye. Curr Eye Res. 1995;14:693-701.
50. Nishida A, Togari H. Effect of vitamin E administration on alpha-tocopherol concentrations in the retina, choroid, and vitreous body of human neonates. J Pediatr. 1986;108:150-153.
51. Chucair AJ, Rotstein NP, Sangiovanni JP, During A, Chew EY, Politi LE. Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid. Invest Ophthalmol Vis Sci. 2007;48:5168-5177.
52. Ernster L, Forsmark-Andree P. Ubiquinol: an endogenous antioxidant in aerobic organisms. Clin Investig. 1993;71:S60-S65.
53. Nucci C, Tartaglione R, Cerulli A, et al. Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. Int Rev Neurobiol. 2007;82:397-406.
54. Kagan VE, Fabisiak JP, Quinn PJ. Coenzyme Q and vitamin E need each other as antioxidants. Protoplasma. 2000;214:11-18.
55. Navas P, Villalba JM, de Cabo R. The importance of plasma membrane coenzyme Q in aging and stress responses. Mitochondrion. 2007;7(suppl):S34-S40.
56. Damian MS, Ellenberg D, Gildemeister R, et al. Coenzyme Q10 combined with mild hypothermia after cardiac arrest: a preliminary study. Circulation. 2004;110:3011-3016.
57. Gvozdjáková A, Simko F, Kucharská J, Braunová Z, Psenek P, Kyselovic J. Captopril increased mitochondrial coenzyme Q10 level, improved respiratory chain function and energy production in the left ventricle in rabbits with smoke mitochondrial cardio-myopathy. Biofactors. 1999;10:61-65.
58. Witting PK. Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercho-lesterolemic young adults. Free Radic Biol Med. 2000;29:295-305.
59. Sandor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005;4:713-715.
60. Shults CW, Beal MF, Fontaine D, Nakano K, Haas RH. Absorption, tolerability and effects on mitochondrial activity of oral coenzyme Q[10] in Parkinsonian patients. Neurology. 1998;50:793-795.
61. Feher J, Kovacs B, Kovacs I, Schveoller M, Papale A, Balacco Gabrieli C. Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. Ophthalmologica. 2005;219:154-166.
62. Feher J, Papale A, Mannino G, Gualdi L, Balacco Gabrieli C. Mitotropic compounds for the treatment of age-related macular degeneration; the metabolic approach and a pilot study. Ophthalmologica. 2003;217:351-357.
63. Blasi MA, Bovina C, Carella G, et al. Does coenzyme Q10 play a role in opposing oxidative stress in patients with age-related macular degeneration? Ophthalmologica. 2001;215:51-54.